Vanda Pharmaceuticals (VNDA) was a big mover last session, as its shares rose over 8% on the day. The upside was driven by the company’s second-quarter financial result announcement. This also led to far more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company since Jul 15, as the stock is now down over 8% in the past one-month time frame.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Vanda Pharmaceuticals currently has a Zacks Rank #2 (Buy).
Another favorably-ranked biomedical stock is Actelion Ltd. (ALIOF) with a Zacks Rank #1 (Strong Buy).
Is VNDA going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment